Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is FOSAMPRENAVIR CALCIUM USP, with a corresponding US DMF Number 25578.
Remarkably, this DMF maintains an Active status since its submission on November 29, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 08, 2015, and payment made on December 26, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II